Brochure Algeria

>>Brochure Algeria
Brochure Algeria 2017-01-27T17:20:58+00:00

Why You Should be Conducting Clinical Trials in Algeria

  • Fast subject enrollment and easy access to medical centers
  • Large number of drug naïve patients
  • Well educated medical professionals and centralized medical system
  • High incidence of “modern world” diseases
  • Fast regulatory approval process maximum 2 months from submission to approval
  • Adherence to International and Algerian guidelines
  • Cost savings based on lower labor and total healthcare costs
Download our Brochure (PDF – 6.5 Mo)
Map of of Algeria

Regulatory Applications in algeria

Algeria is a very attractive destination for fast enrollment across a wide spectrum of therapeutic areas particularly in: naive patients, cardiovascular and metabolic disorders and orphan diseases. At this time, the majority of ongoing studies are being conducted by large pharmaceutical companies.

The Ministry of Health or «Le Ministère de la Santé de la Population et la Réforme Hospitalière» oversees clinical trials in Algeria and requires adherence to Algerian and IC H guidelines for the conduct of clinical trials in Algeria.

The submission of clinical trial application in Algeria is sequential. The dossier must be first submitted to an Ethical Committee accredited by the Ministry of Heath. All study sites are submitted to a single Committee. Once the study is approved by the Ethical Committee it is then submitted to the Ministry of Health for final review and approval. Import and export licenses can only be requested once the study is approved by the Ministry of Health.

Quick facts about Algeria

The population of Algeria is considered primarily Caucasian. The majority of the population is a genetically diverse indigenous group, whose ancestral stock includes Phoenicians, Romans, Byzantines, Arabs, Turks and other ethnic groups.

Algeria is geographically close to the Europe and is only a two hour flight from Paris. It is the tenth largest country in the world, the second largest country in Africa and the largest of the countries bordering the Mediterranean Sea. Algeria has estimated population of 39.7 million people as of 2013.

As of 2011, the Health infrastructure in Algeria comprised of 13 University Hospitals, 34 specialized Hospitals, 460 polyclinics, 1110 medical centers and 3600 basic health units. Health services are provided by the public sector, although a small private sector comprising close to 20% of Algerian physicians co-exist. In 2007, the total number of hospital beds was 61,800 including 35,000 general hospital beds, 3,500 maternity beds, 9,800 specialized hospital beds, 12,600 University hospital beds, and 4,200 private clinic beds. The government plans on spending 28.5 US dollars to double the number of hospitals beds focusing on maternity and cancer wards, and renovating over 12,000 existing hospital beds in 320 public hospitals.

Algeria is a regional power. Algeria is classified as an upper middle income country by the World Bank. The United States is Algeria’s top trading partner, accounting for nearly 25% of exports. The Algerian government is a Constitutional Republic, allowing that no political association may be formed «based on differences in religion, language, race, gender or region.»

There are 3 languages spoken in Algeria: Modern Standard Arabic is the official language, French is widely used in government, culture, media and education and Berber. More recent generations also understand and can communicate in English. Like most new generations, Algerian youth is more fluent in English.

We are responsible, responsive, committed and flexible

ARIANNE has a strong international regulatory understanding, and a corporate commitment to partnership development and long-term relationships with a strong team approach.

ARIANNE is fully compliant with ICH, GCP and regional guidelines and provides a global reach as well as cost-effective solutions.

Download our Brochure (PDF – 6.5 Mo)

ARIANNE has an office in Algiers, the capital of Algeria

We maintain strong relationships with local hospitals and medical centers. Locally, we are closely involved in training and managing all site personnel involved in our studies. Worldwide, all of our offices follow the established quality assurance systems, standard operating procedures to maintain quality and ensure compliance with all regulations and study requirements as our North American Offices as well as adhering to international guidelines. Our foreign staff is fluent in the native languages and English and maintains the appropriate infrastructure to support the studies we conduct, including concise communications and information technology systems.